ClinicalTrials.govpublic full text
Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia
blastic plasmacytoid dendritic cell neoplasm (bpdcn), acute myeloid leukemia (aml), interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 886232
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.